Pascal Sorio

CEO

· tracked since Jun 2026

Calls 1 1 Posts tracked · 1.0/day Posted today

Calls

7d 1

30d 1

90d 1

Win Rate - Long 1 Short 0

Win Rate

7d —

30d —

90d —

Average Return - Long Return - Short Return -

Average Return

7d —

30d —

90d —

Ticker

Side

Mentions

Opened

Entry

P&L

Thesis

Theme

Source

AZN AstraZeneca PLC AstraZeneca PLC

Long

Jun 05

$185.95

AstraZeneca on track for $80B

AstraZeneca is on track to hit its ambitious $80 billion total revenue target by 2030, driven by a strong oncology pipeline, new product launches (breast cancer, hypertension), and investments in manufacturing and R&D.

Healthcare

YOUTUBE

Showing 1 of 1 picks · sorted by mentions